Latanoprost Completed Phase 3 Trials for Glaucoma / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00800267A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
NCT02105272Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT00716859A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
NCT01156012Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients
NCT02154217Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures